Affiliation:
1. Department of Neurology University of Virginia School of Medicine Charlottesville Virginia USA
2. Clinical Observer, Epilepsy Center Cleveland Clinic Cleveland Ohio USA
3. Epilepsy Center Cleveland Clinic Cleveland Ohio USA
4. Department of Neurosciences Université de Montréal Montreal Quebec Canada
Abstract
AbstractOlder adults constitute a large proportion of people with epilepsy (PWE) due to the changing demographics worldwide and epilepsy's natural history. Aging‐related pathophysiological changes lower the tolerance and increase our vulnerability to stressors, which manifests as frailty. Frailty is closely associated with adverse health outcomes. This narrative review examines the interplay between frailty and epilepsy, especially in older adults, emphasizing its clinical implications, including its role in managing PWE. Mechanistically, frailty develops through complex interactions among molecular and cellular damage, including genomic instability, mitochondrial dysfunction, and hormonal changes. These contribute to systemic muscle mass, bone density, and organ function decline. The concept of frailty has evolved from a primarily physical syndrome to include social, psychological, and cognitive dimensions. The “phenotypic frailty” model, which focuses on physical performance, and the “deficit accumulation” model, which quantifies health deficits, provide frameworks for understanding and assessing frailty. PWE are potentially more prone to developing frailty due to a higher prevalence of risk factors predisposing to frailty. These include, but are not limited to, polypharmacy, higher comorbidity, low exercise level, social isolation, low vitamin D, and osteoporosis. We lack commercial biomarkers to measure frailty but can diagnose it using self‐ or healthcare provider‐administered frailty scales. Recent attempts to develop a PWE‐specific frailty scale are promising. Unlike chronological age, frailty is reversible, so its management using multidisciplinary care teams should be strongly considered. Frailty can affect antiseizure medication (ASM) tolerance secondary to its impact on pharmacokinetics and pharmacodynamics. While frailty's effect on seizure control efficacy of ASM is poorly understood, its undoubted association with overall poor outcomes, including epilepsy surgery, behooves us to consider its presence and implication while treating older PWE. Incorporation of frailty measures in future research is essential to improve our understanding of frailty's role in PWE health.Plain Language SummaryFrailty is the declining state of the human body. People with epilepsy are more prone to it. It should be factored into their management.
Reference92 articles.
1. The power of global aging;Powell JL;Ageing Int,2010
2. Ageing as a Risk Factor for Disease
3. Merriam‐Webster. Available from:www.merriam‐webster.com
4. WHO.WHO Clinical Consortium on Healthy Ageing Topic Focus: Frailty and Intrinsic Capacity.2016.
5. Management of frailty: opportunities, challenges, and future directions